PRCT director granted RSUs and stock options
PROCEPT BioRobotics director Taylor C. Harris received new equity awards as part of director compensation.
Rhea-AI Filing Summary
PROCEPT BioRobotics director Taylor C. Harris received new equity awards as part of director compensation. He was granted 3,315 restricted stock units, each representing one share of Common Stock, and 5,853 stock options with an exercise price of $28.78 per share. Both the RSUs and options vest in full on the earlier of the one-year anniversary of the June 9, 2026 grant date or the next annual meeting, subject to continued service. After this award, Harris directly holds 102,491 shares of Common Stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 9,168 shares
Grant/Award
2 txns
Insider
Harris Taylor C.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 5,853 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 3,315 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 5,853 contracts (Direct);
Common Stock — 102,491 shares (Direct)
Footnotes (2)
- F1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
- F2. The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Key Figures
RSU grant: 3,315 RSUs
Stock options granted: 5,853 options
Option exercise price: $28.78 per share
+3 more
6 metrics
RSU grant
3,315 RSUs
Restricted stock units granted June 9, 2026
Stock options granted
5,853 options
Director stock option award on June 9, 2026
Option exercise price
$28.78 per share
Stock option strike price
Option expiration
June 8, 2036
Option expiration date
Shares held after grant
102,491 shares
Total Common Stock directly held after awards
Underlying shares for options
5,853 shares
Common Stock underlying new stock options
Key Terms
restricted stock units (RSUs), Stock Option (Right to Buy), exercise price, vesting, +1 more
5 terms
restricted stock units (RSUs) financial
"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 28.7800 per share."
exercise price financial
"conversion_or_exercise_price: "28.7800" for the stock option grant."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The securities shall vest in full on the earlier to occur of the one-year anniversary of the grant date, or the date of the next annual meeting."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting financial
"vest in full on the earlier of the one-year anniversary of the grant date, or the date of the next annual meeting."
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PROCEPT BioRobotics (PRCT) director Taylor C. Harris receive in this Form 4?
Taylor C. Harris received equity-based compensation consisting of 3,315 restricted stock units and 5,853 stock options. These awards increase his direct equity exposure to PRCT and are granted at no cash cost to him at the time of grant.
What are the key terms of the stock options granted to the PRCT director?
The director received 5,853 stock options with an exercise price of $28.78 per share. These options vest in full on the earlier of the one-year anniversary of the June 9, 2026 grant date or the next annual meeting, subject to continued service.
How do the restricted stock units (RSUs) for PROCEPT BioRobotics (PRCT) vest?
The 3,315 RSUs vest in full on the earlier of the one-year anniversary of the June 9, 2026 grant date or the next annual meeting. Vesting is contingent on the director’s continued service through the applicable vesting date.
Are these PRCT Form 4 transactions open-market purchases or sales?
These transactions are compensation-related grants, not open-market trades. The director acquired 3,315 RSUs and 5,853 stock options as awards, with no reported open-market buying or selling of PROCEPT BioRobotics Common Stock in this Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
